UPS is shelling out nearly $50 million on temperature-controlled facilities to meet the booming demand for GLP-1 deliveries (opens in new tab)

Covers Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford

Freight giants have pivoted to healthcare logistics, which they see as recession-proof.

Read the original article

Sign in to keep reading the full article.